Epidemiologic factors associated with mortality among hospitalized adult patients with COVID-19 in the state of Jalisco, Mexico

Q4 Medicine Medicina Interna de Mexico Pub Date : 2021-06-03 DOI:10.24245/mim.v37i3.5107
C. A. Andrade-Castellanos, L. Colunga-Lozano
{"title":"Epidemiologic factors associated with mortality among hospitalized adult patients with COVID-19 in the state of Jalisco, Mexico","authors":"C. A. Andrade-Castellanos, L. Colunga-Lozano","doi":"10.24245/mim.v37i3.5107","DOIUrl":null,"url":null,"abstract":"BACKGROUND: The SARS-CoV-2 outbreak is a significant challenge to the healthcare system in Mexico;some regions are already struggling to fight the virus. OBJECTIVE: To identify comorbidities of adult patients with COVID-19 treated in hospitals in Jalisco and to assess their associations with the risk of death. MATERIALS AND METHODS: An observational, analytical, retrospective study in which we obtained data of confirmed COVID-19 cases and their characteristics from epidemiological surveillance system of the Mexican Health Secretary through Feb 27, 2020 to November 30, 2020. RESULTS: We included 5590 patients with a mean age of 58 years, 62% were men;overall mortality was 38%. The most common concomitant conditions were hypertension, diabetes and obesity. The multivariate analysis found that chronic kidney disease (OR = 2.71), obesity (OR = 1.24), chronic obstructive pulmonary disease (OR = 1.21), diabetes mellitus (OR = 1.15) and hypertension (OR = 1.13) were independent risk factors associated with mortality. CONCLUSIONS: The risk of dying was clearly higher in individuals with comorbidities, particularly among people with chronic kidney disease or obesity.","PeriodicalId":35750,"journal":{"name":"Medicina Interna de Mexico","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Interna de Mexico","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24245/mim.v37i3.5107","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND: The SARS-CoV-2 outbreak is a significant challenge to the healthcare system in Mexico;some regions are already struggling to fight the virus. OBJECTIVE: To identify comorbidities of adult patients with COVID-19 treated in hospitals in Jalisco and to assess their associations with the risk of death. MATERIALS AND METHODS: An observational, analytical, retrospective study in which we obtained data of confirmed COVID-19 cases and their characteristics from epidemiological surveillance system of the Mexican Health Secretary through Feb 27, 2020 to November 30, 2020. RESULTS: We included 5590 patients with a mean age of 58 years, 62% were men;overall mortality was 38%. The most common concomitant conditions were hypertension, diabetes and obesity. The multivariate analysis found that chronic kidney disease (OR = 2.71), obesity (OR = 1.24), chronic obstructive pulmonary disease (OR = 1.21), diabetes mellitus (OR = 1.15) and hypertension (OR = 1.13) were independent risk factors associated with mortality. CONCLUSIONS: The risk of dying was clearly higher in individuals with comorbidities, particularly among people with chronic kidney disease or obesity.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
与墨西哥哈利斯科州COVID-19住院成年患者死亡率相关的流行病学因素
背景:SARS-CoV-2疫情对墨西哥的卫生保健系统构成重大挑战;一些地区已经在努力抗击该病毒。目的:确定哈利斯科州医院治疗的成年COVID-19患者的合并症,并评估其与死亡风险的关系。材料和方法:一项观察性、分析性、回顾性研究,从墨西哥卫生部长的流行病学监测系统中获取2020年2月27日至2020年11月30日的COVID-19确诊病例及其特征数据。结果:我们纳入5590例患者,平均年龄58岁,62%为男性,总死亡率为38%。最常见的伴随疾病是高血压、糖尿病和肥胖。多因素分析发现,慢性肾脏疾病(OR = 2.71)、肥胖(OR = 1.24)、慢性阻塞性肺疾病(OR = 1.21)、糖尿病(OR = 1.15)和高血压(OR = 1.13)是与死亡相关的独立危险因素。结论:有合并症的患者死亡风险明显更高,特别是慢性肾脏疾病或肥胖患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Medicina Interna de Mexico
Medicina Interna de Mexico Medicine-Internal Medicine
CiteScore
0.30
自引率
0.00%
发文量
137
期刊介绍: La revista Medicina Interna de México es el órgano oficial del Colegio de Medicina Interna de México Reserva de Titulo de la Dirección General del Derecho de Autor (SEP) número 04-2001-112110545900.-102 certificado de Licitud de Titulo número 11967 y Certilicado de Licitud de Contenido de la Comisión Catificadora de Publicaciones y Revistas Ilustradas (SeGob) número 8375. AutorIzada por SEPOMEX como Publicación Penódica Registro número PPO9- 0884
期刊最新文献
The evolution of pharmacological treatment of COVID-19 COVID-19, that global parenthesis Cardiovascular, hematological and renal implications of COVID-19 Acute kidney injury as a predictor of hospital discharge in COVID-19 patients Telogen effluvium and alopecia areata: Associated symptoms in patients with long COVID-19
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1